“창원핸플🎅🏻 〈OPdal040.COM≥오피달리기 ☕️창원마사지📡창원건마🏀창원립카페🙇창원풀싸롱🙄창원출장안마✊창원안마👧”的搜索结果，显示 111-120 项，共有 10196 项

1. 肺静脉隔离术 - 医生与科室 - 妙佑医疗国际

   这种心脏消融术使用热能或冷能来治疗心房颤动。了解如何完成，以及何时需要进行此项治疗。

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180 ... ≥ 40). T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180 ... ≥ 40). T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Borderline Resectable Pancreatic Cancer - Tumor-vessel interface ≥180 ... ≥ 40). T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

8. 神经外科- 临床试验- 妙佑医疗国际

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a neutrophil ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. The purpose of this study is to evaluate the objective response rate (ORR) by RECIST 1.1 in subjects with TPS ≥ 1 percent. The ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...